Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
Status:
Completed
Trial end date:
2018-03-16
Target enrollment:
Participant gender:
Summary
Compare the Efficacy and Safety of Metformin/Rosuvastatin Combination Therapy With Metformin
or Rosuvastatin Monotherapy in Patients With Type 2 Diabetes and Dyslipidemia